Chinese PLA General Hospital
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Hepatology 1.3k
- Hepatocellular Carcinoma Treatment and Prognosis 890
- Sensory Systems 532
- Hearing, Cochlea, Tinnitus, Genetics 517
- Top scholars
- Xiaobing FuWeidong HanXiangmei ChenYong-ming YaoHao ZhouPing LiangFu‐Sheng WangPeifu Tang
- Journals
- Scientific Reports (381 papers)PLoS ONE (332 papers)Medicine (265 papers)Frontiers in Oncology (263 papers)Frontiers in Immunology (255 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Chinese PLA General Hospital
29k papers receiving 582.6k citations
Peers
Comparison fields: 5 of 244
- Cancer Research 29.2k
- Hepatology 17.8k
- Genetics 17.3k
- Molecular Medicine 11.9k
- Oncology 39.7k
Countries citing scholars working at Chinese PLA General Hospital
This map shows the geographic impact of research produced by authors working at Chinese PLA General Hospital. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Chinese PLA General Hospital with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chinese PLA General Hospital more than expected).
Fields of papers published by authors at Chinese PLA General Hospital
This network shows the impact of papers affiliated with Chinese PLA General Hospital at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Chinese PLA General Hospital at the time of their publication.
About Chinese PLA General Hospital
In recent decades, authors affiliated with Chinese PLA General Hospital have published 31.5k papers, which have received a total of 583.1k indexed citations . Scholars at this organization have produced 1.3k papers in Hepatology, 532 papers in Sensory Systems, 869 papers in Genetics, 2.1k papers in Oncology and 2.8k papers in Pulmonary and Respiratory Medicine on the topics of Hepatocellular Carcinoma Treatment and Prognosis (890 papers), Mesenchymal stem cell research (565 papers), Hearing, Cochlea, Tinnitus, Genetics (517 papers), Cancer Immunotherapy and Biomarkers (455 papers), MicroRNA in disease regulation (433 papers), Gastric Cancer Management and Outcomes (412 papers), Wound Healing and Treatments (400 papers) and Bone Tissue Engineering Materials (376 papers). Their work is cited by papers focused on Cancer Research (29.2k citations), Hepatology (17.8k citations), Genetics (17.3k citations), Molecular Medicine (11.9k citations) and Oncology (39.7k citations). Authors at Chinese PLA General Hospital collaborate with scholars in China, United States and United Kingdom and have published in prestigious journals including Scientific Reports, PLoS ONE, Medicine, Frontiers in Oncology and Frontiers in Immunology. Some of Chinese PLA General Hospital's most productive authors include Xiaobing Fu, Weidong Han, Xiangmei Chen, Yong-ming Yao, Hao Zhou, Ping Liang, Fu‐Sheng Wang, Peifu Tang, Guozhen Shen and Chao Zhang.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.